Literature DB >> 1618255

Influence of verapamil on the coronary arteriovenous difference in long chain free fatty acids in hypertrophic cardiomyopathy.

J S Dubiel1, J Jaśkiewicz, K Zmudka, T Brzostek, A Surdacki.   

Abstract

The percentage composition of free fatty acids in the coronary circulation has been studied during the passage of blood through the heart in patients with hypertrophic cardiomyopathy. Under basal conditions the percentages of palmitic and stearic acid decreased significantly. Verapamil i.v. produced a tendency towards a preferential myocardial uptake of oleic acid.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1618255     DOI： 10.1007/bf00278488

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  6 in total

1.  An easy colorimetric micromethod for routine determination of free fatty acids in plasma.

Authors:  K Falholt; B Lund; W Falholt
Journal:  Clin Chim Acta       Date:  1973-06-28       Impact factor: 3.786

2.  Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS.

Authors:  W L Henry; C E Clark; S E Epstein
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

Review 3.  Metabolism of the heart in health and disease. II.

Authors:  L H Opie
Journal:  Am Heart J       Date:  1969-01       Impact factor: 4.749

4.  Use of thin-layer chromatography on silica gel for serum lipid fractionation and measurement in the routine clinical laboratory.

Authors:  A Chedid; P Haux; S Natelson
Journal:  Clin Chem       Date:  1972-04       Impact factor: 8.327

5.  Use of calcium channel blockers in hypertrophic cardiomyopathy.

Authors:  B H Lorell
Journal:  Am J Med       Date:  1985-02-22       Impact factor: 4.965

Review 6.  Calcium and catecholamines: relevance to cardiomyopathies and significance in therapeutic strategies.

Authors:  L H Opie; B Walpoth; R Barsacchi
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.